A detailed history of Hrt Financial LP transactions in Orasure Technologies Inc stock. As of the latest transaction made, Hrt Financial LP holds 128,997 shares of OSUR stock, worth $466,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,997
Previous 391,549 67.05%
Holding current value
$466,969
Previous $1.67 Million 67.01%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.93 - $4.59 $1.03 Million - $1.21 Million
-262,552 Reduced 67.05%
128,997 $550,000
Q2 2024

Aug 12, 2024

BUY
$4.2 - $6.18 $226,144 - $332,755
53,844 Added 15.94%
391,549 $1.67 Million
Q1 2024

May 13, 2024

BUY
$6.08 - $8.28 $2.05 Million - $2.8 Million
337,705 New
337,705 $2.08 Million
Q3 2023

Nov 13, 2023

BUY
$4.4 - $6.91 $5,821 - $9,141
1,323 Added 6.71%
21,033 $124,000
Q2 2023

Aug 11, 2023

BUY
$4.88 - $7.39 $32,578 - $49,335
6,676 Added 51.22%
19,710 $98,000
Q1 2023

May 12, 2023

SELL
$4.66 - $6.52 $870,119 - $1.22 Million
-186,721 Reduced 93.48%
13,034 $78,000
Q4 2022

Feb 10, 2023

BUY
$3.7 - $5.29 $598,571 - $855,795
161,776 Added 425.96%
199,755 $962,000
Q3 2022

Nov 14, 2022

BUY
$2.72 - $4.61 $103,302 - $175,083
37,979 New
37,979 $143,000
Q2 2022

Aug 12, 2022

SELL
$2.71 - $7.12 $86,221 - $226,529
-31,816 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.62 - $9.33 $210,621 - $296,843
31,816 New
31,816 $215,000
Q4 2021

Feb 14, 2022

SELL
$8.3 - $11.29 $200,104 - $272,190
-24,109 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.73 - $13.38 $234,580 - $322,578
24,109 New
24,109 $272,000
Q4 2019

Feb 14, 2020

SELL
$7.21 - $8.89 $80,514 - $99,274
-11,167 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$6.57 - $9.46 $73,367 - $105,639
11,167 New
11,167 $83,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $263M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.